Rapid Influenza Diagnostics Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Rapid Influenza Diagnostics Market in 2025 is assessed at USD 983.69 million. The global Market size exceeded USD 921.75 million in 2024 and is set to expand at a CAGR of more than 8.4%, surpassing USD 2.63 billion revenue by 2037. North America is anticipated to exceed USD 867.9 million by 2037, attributed to presence of key players and rising influenza cases.
The growth of this market can be attributed to the growing prevalence of influenza all around the world. The increasing number of people globally found with weak immunity systems suffering from target ailments are expected to raise the industry growth in the forthcoming years. Human influenza viruses consisting of Type A and Type B influenza are the most significant viruses that cause disease risk in humans. These issues contribute to healthcare costs and also disrupt health-associated quality of life. As per a report by the World Health Organization, globally around 3 – 5 million people suffer from severe cases of influenza.
The increased R&D spending for the provision of technically advanced solutions to diagnose influenza is expected to lead to a higher rate of global adoption of these tests. The market revenue for these tests is expected to expand over the coming years due to the widespread use of rapid influenza diagnostic testing and a growing incidence of influenza.
